Business Wire

Corsearch Announces Strategic Partnerships with Key-Systems GmbH and INCOPRO

Share

Corsearch, a premier provider of clearance and protection solutions for trademark and brand professionals, is pleased to announce strategic partnerships with Key-Systems, a global player in the internet and domain industry, and INCOPRO, a leading online IP and brand protection company. The agreements solidify Corsearch’s full service domain management and brand protection offerings for law firms .

“We are thrilled to be moving forward in a new partnership with Key Systems to complement our existing partnership with COM LAUDE, and to be expanding the partnership we have with INCOPRO,” said Corsearch President and CEO Tobi Hartmann. “These relationships will allow Corsearch to expand its domain name management and brand protection solutions for law firms and their end clients.”

Corsearch & Key-Systems Partnership

Working with the corporate domain management solution “BrandShelter", Corsearch will provide law firms an easy way to manage the domain portfolios of their clients. This collaboration will provide law firms powerful and stable domain management through one of the largest registrars in Europe.

“We are excited to have won Corsearch as a partner,” said Alexander Siffrin, Key-Systems CEO. “Our customers will benefit from our joint expertise and excellence.”

In addition to the fully automated and white labeled interface, this cooperation allows Corsearch and Key-Systems to provide a dedicated account management team of industry experts, automatic renewal of all domains in management, and a completely automated and customizable billing system which is able to send invoices in the law firm’s name with the given pricing for their clients.

Corsearch & INCOPRO Partnership

Corsearch & INCOPRO today announce a renewal of their collaboration aimed at enabling law firms to deliver strategic advice and online enforcement for their clients. Corsearch will offer a law firm edition of INCOPRO’s innovative brand protection technology, providing law firms with the technology to defend their clients’ intellectual property from online abuse.

“As a lawyer myself, I know that technology has a huge role to play in enabling law firms to deliver strategic and cost-effective advice and support to clients,” said INCOPRO CEO Simon Baggs. “INCOPRO is thrilled to be working with Corsearch in delivering this new and exciting solution.”

Online IP infringement is a rapidly growing challenge for all brands as e-commerce expands and digital becomes the core business strategy. Using the Corsearch INCOPRO platform, law firms can efficiently identify the strategic challenges affecting their clients’ brands, adding to the value they offer their clients and strengthening their IP services.

Corsearch will be the exclusive provider of this law firm edition of the INCOPRO system, offering a market-leading proposition to its law firm clients. Corsearch & INCOPRO first partnered in 2016 and this new proposition reinforces the strength of the partnership.

About Corsearch

Corsearch is a premier provider of clearance and protection solutions for trademark and brand professionals. Its high-quality, intuitive tools and unparalleled expertise enable professionals to effectively manage their trademark screening, search review, watching, and domain management processes. With highly trained researchers, an expansive global content set and customer-focused technology tools available through the Corsearch platform, Corsearch empowers its customers with powerful brand solutions in an increasingly complex business environment.

For more information visit Corsearch.com.

About Key-Systems

Founded in 1998, Key-Systems is a global player of the internet and domain industry. Its core business is the registration of internet addresses – Key-Systems currently manages more than 5 million domains on behalf of its customers.

Besides domain registrations, Key-Systems' three differently targeted business divisions and the two wholly owned subsidiaries offer comprehensive IT services. These include the operation of a registry, colocation, virtual servers, web hosting, SSL certificates and brand monitoring on the Internet.

Key-Systems serves customers all over the world, among them are private clients, mid-sized businesses, well-known domain investors as well as large international organizations and corporations. With diversified offerings, trusted technique, and our experienced team of more than 100 domain experts Key-Systems expanded its customer base to more than 100,000 retail/corporate customers and over 2,300 resellers worldwide. For more information regarding Key-Systems GmbH, visit www.key-systems.net.

About INCOPRO

Founded in 2011, INCOPRO is an online IP and brand protection company. Its proprietary technology platform TALISMAN collates data on brand infringement and automatically identifies and prioritizes IP violations. Its clustering technology is uniquely able to track and connect the commercial scale counterfeiters, enabling comprehensive takedown of all associated operations. Headquartered in London, with INCOPRO’s analysts working across the United States, Europe, and Asia, INCOPRO works with some of the largest global brands to provide connected and actionable insights into IP infringements online. For additional information regarding INCOPRO, please visit www.incoproip.com.

Contact information

Corsearch
Brett Amdur, 800-732-7241
Chief Marketing and Strategy Officer

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Approves OTEZLA® (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease19.7.2019 17:59:00 CESTPress release

Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast) 30 mg twice daily (BID) for the treatment of adult patients with oral ulcers associated with Behçet’s Disease. OTEZLA, an oral, selective inhibitor of phosphodiesterase 4 (PDE4), is the first and only approved treatment option for oral ulcers associated with Behçet’s Disease, a rare, chronic, multisystem inflammatory disease that is difficult to treat. “Oral ulcers are a recurring and debilitating manifestation that affects nearly everyone living with Behçet’s Disease, and have an important negative impact on the quality of life for these patients,” said Yusuf Yazici, M.D., Clinical Associate Professor, Department of Medicine, New York University Langone Health. “In the clinical trial, OTEZLA demonstrated improvements in measures of oral ulcers at week 12. OTEZLA has the potential to be a needed treatment option for U.S. patients and their physicians, who

Abiraterone Acetate Included in World Health Organisation’s Essential Medicines List for the Treatment of Metastatic Castration-Resistant Prostate Cancer19.7.2019 13:05:00 CESTPress release

The Janssen Pharmaceutical Companies of Johnson & Johnson is delighted with the recent announcement from the World Health Organisation (WHO) to include abiraterone acetate (ZYTIGA ® ) for the treatment of metastatic castration-resistant prostate cancer (mCRPC), in the updated Essential Medicines List, published on 9th July 2019.1,2 The WHO’s Essential Medicines List is a core guidance document that helps countries prioritise critical health products that are recommended to be widely available and affordable throughout health systems.1 “The inclusion of abiraterone acetate in the WHO Essential Medicines List highlights the critical role that this treatment can play in improving the lives of patients living with mCRPC and their families,” said Dr. Joaquín Casariego, Janssen Therapeutic Area Lead Oncology for Europe, Middle East & Africa, Janssen-Cilag S.A. “I am proud that we are working hard to impact survival and quality of life by developing and providing innovative medicines which ar

Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis19.7.2019 12:30:00 CESTPress release

Gilead Sciences, Inc. (NASDAQ: GILD) announced today that it has licensed three preclinical antiviral programs from Novartis, including investigational agents with the potential to treat human rhinovirus, influenza and herpes viruses. Under the agreement, Gilead will acquire exclusive global rights to develop and commercialize novel small molecules against three undisclosed targets. Novartis will receive an upfront payment and is eligible to receive up to an additional $291 million in potential milestone payments upon achievement of certain development and commercial milestones, as well as royalties on annual net sales. “Today’s announcement builds on Gilead’s heritage in antiviral research and development. We look forward to applying this expertise to advance the development of potential new treatments for viruses with limited therapeutic options,” said John McHutchison AO, MD, Gilead’s Chief Scientific Officer and Head of Research and Development. Gilead’s antiviral portfolio include

Schlumberger Announces Second-Quarter 2019 Results19.7.2019 11:00:00 CESTPress release

Schlumberger Limited (NYSE: SLB) today reported results for the second quarter of 2019. (Stated in millions, except per share amounts) Three Months Ended Change Jun. 30, 2019 Mar. 31, 2019 Jun. 30, 2018 Sequential Year-on-year Revenue $8,269 $7,879 $8,303 5% 0% Pretax segment operating income $968 $908 $1,094 7% -12% Pretax segment operating margin 11.7% 11.5% 13.2% 17 bps -148 bps Net income - GAAP basis $492 $421 $430 17% 14% Net income, excluding charges & credits* $492 $421 $594 17% -17% Diluted EPS - GAAP basis $0.35 $0.30 $0.31 17% 13% Diluted EPS, excluding charges & credits* $0.35 $0.30 $0.43 17% -19% North America revenue $2,801 $2,738 $3,139 2% -11% International revenue $5,463 $5,037 $5,065 8% 8% North America revenue, excluding Cameron $2,243 $2,178 $2,546 3% -12% International revenue, excluding Cameron $4,761 $4,469 $4,387 7% 9% *These are non-GAAP financial measures. See section titled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commente

Schlumberger Appoints Olivier Le Peuch as CEO19.7.2019 10:46:00 CESTPress release

Schlumberger Limited (NYSE: SLB) announced today that its Board of Directors has appointed Olivier Le Peuch as its Chief Executive Officer and member of the Schlumberger Board, effective August 1, 2019. Mr. Le Peuch succeeds Paal Kibsgaard, who will retire as Chief Executive Officer effective that same date. Also effective August 1, Mr. Kibsgaard will step down as Chairman of the Board and retire as a member of the Board of Directors. Mr. Kibsgaard will retire after more than 22 years of service to the Company, including eight years as CEO and four years as Chairman. Effective the same date, Mark G. Papa, a current non-independent director, will become non-executive Chairman of the Board. Peter Currie will continue to serve as the Board’s Lead Independent Director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190719005161/en/ Olivier Le Peuch is appointed Chief Executive Officer and a member of the Schlumberger Board, effe

Fluke Corporation Acquires Industrial Reliability Leader PRÜFTECHNIK19.7.2019 10:00:00 CESTPress release

Fluke Corp., the global leader in test and measurement instruments, has acquired Ismaning, Germany-based PRÜFTECHNIK, a market leader in precision laser shaft alignment, condition monitoring, and non-destructive testing. “Fluke’s acquisition of PRÜFTECHNIK reflects the growing importance our customers place on reliability systems to keep their equipment in optimum operating condition,” said Marc Tremblay, president of Fluke Corporation. “This business will help us usher in the next generation of solutions for our industrial customers.” Fluke Corporation For information on Fluke tools and applications, or to find the location of your nearest distributor, contact Fluke Corporation, P.O. Box 9090, Everett, WA USA 98206, call (800) 44-FLUKE (800-443-5853), fax (425) 446-5116, e-mail fluke-info@fluke.com or visit the Fluke Web site at http://www.fluke.com. About Fluke Founded in 1948, Fluke Corporation is the world leader in compact, professional electronic test tools and software for measu